Literature DB >> 21655160

Eyelash trichomegaly secondary to panitumumab therapy.

L G T Morris1, H S Hochster, M D Delacure.   

Abstract

Entities:  

Keywords:  Panitumumab; epidermal growth factor receptor; eyelash; hair; targeted therapy; trichomegaly

Year:  2011        PMID： 21655160      PMCID： PMC3108868          DOI： 10.3747/co.v18i3.762

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  5 in total

1.  Trichomegaly of the eyelashes following treatment with cetuximab.

Authors:  O Bouché; H Brixi-Benmansour; A Bertin; G Perceau; S Lagarde
Journal:  Ann Oncol       Date:  2005-06-21       Impact factor: 32.976

2.  Eye complications of cetuximab therapy.

Authors:  B Melichar; I Nemcová
Journal:  Eur J Cancer Care (Engl)       Date:  2007-09       Impact factor: 2.520

Review 3.  Review article: panitumumab--a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer.

Authors:  M Peeters; J Balfour; D Arnold
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

4.  Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.

Authors:  Grace Zhang; Surendra Basti; Lee M Jampol
Journal:  Cornea       Date:  2007-08       Impact factor: 2.651

Review 5.  Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?

Authors:  Jochen H Lorch; Marshall R Posner; Lori J Wirth; Robert I Haddad
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722
  5 in total
  2 in total

1.  Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.

Authors:  Varun Goel; Shubhra Raina; D Chandragouda; Sajjan Singh; Vineet Talwar; Nivedita Patnaik
Journal:  Int J Trichology       Date:  2014-01

2.  Scanning electron microscopy of panitumumab-induced eyelash and hair alterations - Pili canaliculi.

Authors:  Debora Sarzi Sartori; Antônia Larangeira de Almeida; Gabriel Santana Pereira de Oliveira; Hiram Larangeira de Almeida
Journal:  An Bras Dermatol       Date:  2022-01-15       Impact factor: 2.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.